Cryopexy enhances experimental autoimmune uveoretinitis (EAU) in rats

Area of Science:

• Ophthalmology
• Immunology
• Pathology

Background:

• Experimental autoimmune uveitis (EAU) is a model for human uveitis.
• Cryopexy is a therapeutic modality used in ophthalmology.
• Understanding factors that modulate EAU is crucial for developing treatments.

Purpose of the Study:

• To investigate the effect of cryopexy on the development of EAU in rats.
• To elucidate the mechanisms underlying cryopexy-induced enhancement of EAU.

Main Methods:

• Rats were treated with cryopexy and subsequently induced with EAU.
• Disease severity was assessed clinically and histologically.
• Immunohistochemistry and electron microscopy were used to analyze inflammatory infiltrates and ocular barriers.
• Evans blue angiography was employed to evaluate blood-retinal barrier integrity.

Main Results:

• Cryopexy enhanced EAU development, particularly in low responder strains and with S-antigen sensitization.
• Enhanced EAU manifested as earlier onset and more severe inflammation.
• Histology revealed focal necrosis and inflammation at cryopexy sites.
• Immunohistochemistry identified macrophages and T-lymphocytes (helper and suppressor subsets) in inflammatory infiltrates.
• Increased class II antigen expression was noted on ocular cells.
• Cryopexy induced blood-retinal barrier breakdown at treated sites.

Conclusions:

• Cryopexy enhances EAU by causing blood-retinal barrier breakdown, promoting lymphoid cell accumulation, and increasing antigen presentation via enhanced class II antigen expression.
• Inflammation in cryopexy-treated eyes localizes to the site of injury.
• These findings suggest cryopexy can exacerbate autoimmune ocular inflammation through specific immunological mechanisms.